Журнал. Вестник офтальмологии № 6 — 2020 г.

Обзоры литературы

Literature reviews

36. McKellar MJ, Aburn NS. Cast-forming Actinomyces israelii canaliculitis. Aust N Z J Ophthalmol. 1997;25(4):301-303. 37. Roth M, Montone KT. Actinomycosis o f the paranasal sinuses: a case report and review. Otolaryngol Head Neck Surg. 1996; 114(6):818-821. https://doi.org/10.1016/S0194-59989670109-2 38. Seo JB, Lee JW, Ha SY, Park JW, Jeong SH, Park GY. Primary endobron­ chial actinomycosis associated with b roncho lith iasis. Respiration. 2003; 70( 1): 110-113. https://doi.org/10.1159/000068425 39. Shibasaki M, Iwai T, Chikumaru H, Mitsudo K, Inayama Y, Tohnai I. Ac- tinomyces-associated calcifications in a dentigerous cyst o f the mandible. J Craniofac Surg. 2 0 13;24(3):311-314. https://doi.org/10.1097/SCS.0b013e31828f2e72 40. Woo HJ, Bae CH , Song SY, Choi YS, Kim YD. Actinomycosis o f the para­ nasal sinus. Otolaryngol Head Neck Surg. 2008; 139(3):460-462. https://doi.Org/10.1016/j.otohns.2008.06.001 41. Ayub M, Thale AB, Hedderich J, Tillmann BN, Paulsen FP. The cavernous body o f the human efferent tear ducts contributes to regulation o f tear o u t­ flow. Invest Ophthalmol Vis Sei. 2003;44(ll):4900-4907. 42. Paulsen F, Hallmann U, Paulsen J, Thale A. Innervation o f the cavernous body o f the human efferent tear ducts and function in tear outflow mecha­ nism. JAnat. 2000; 197(Pt 2): 177-187. 43. Paulsen FP, Thale AB, Maune S, Tillmann BN. New insights into the patho­ physiology o f primary acquired dacryostenosis. Ophthalmology. 2001; 108( 12): 2329-2336. 44. Thale A, Paulsen F, Rochels R, Tillmann B. Functional anatomy o f the hu ­ man efferent tear ducts* a new theory o f tear outflow mechanism. Graefes Arch Clin Exp Ophthalmol. 1998;236(9):674-678. 45. Paulsen FP, Schaudig U, Fabian A, Ehrich D, Sei S. T F F peptides and mu­ cins are major components o f dacryoliths. Graefes Arch Clin Exp Ophthalmol. 2006;244(9): 1160-1170. https://doi.org/10.1007/s004I7-005-0167-4 46. Yazici B, Hammad AM, Meyer DR. Lacrimal sac dacryoliths: predictive fac­ tors and clinical characteristics. Ophthalmology. 2001; 108(7): 1308-1312. 47. Herzig S, Hurwitz JJ. Lacrimal sac calculi. Can J Ophthalmol. 1979; 14( 1): 17-20. 48. Andreou P. Rose GE . Clinical presentation o f patients with dacryolithiasis. Ophthalmology. 2002; 109(8): 1573-1574. 49. Kominek P, Cervenka S, Zelenik K, Pniak T, Tomaskova H, Matousek P. Lac­ rimal sac dacryolith (76 cases): a predictive factor for successful endonasal dac­ ryocystorhinostomy? EurArch Otorhinolaryngol. 2014;271 ( 6 ): 1595-1599. https://doi.org/10"l007/s00405-013-2787-3 50. Jones LT. Tear-Sac Foreign Bodies. Am J Ophthalmol. 1965;60:111-113. 51. Lew H, Lee SY, Yun YS. Measurement o f pH , electrolytes and e lectropho­ retic studies o f tear proteins in tears o f patients with dacryoliths: a novel con­ cept for dacryoliths. Ophthalmologica. 2004;218(2): 130-135. https://doi.org/10.1159/000076149 52. Baratz KH, Bartley GB, Campbell RJ, Garrity JA. An eyelash nidus for dac­ ryoliths o f the lacrimal excretory and secretory systems. Am J Ophthalmol. 1*991; 111(5):624-627.

53. Jay JL, Lee WR. Dacryolith formation around an eyelash retained in the lac­ rimal sac. Br J Ophthalmol. 1976;60( 10):722-725. h ttp s ://do i.o rg /10 .! 136/bjo.60.10.722 54. Zafar A, Jordan DR, Brownstein S, Faraji H. Asymptomatic lacrimal duc t­ ule dacryolithiasis with embedded cilia. Ophthalmic Plast Reconstr Surg. 2004;20(l):83-85. https://doi.Org/10.1097/01.IOP.0000105515.10205.A6 55. C io linoJB , Mills DM, Meyer DR. Ocular manifestations o f long-term mas­ cara use. Ophthalmic Plast Reconstr Surg. 2009;25(4):339-341. https://doi.org/10.1097/10p.0b013e3181ab443c 56. Gupta N, Bansal S, G andh i A. Endoscopic view o f mascara laden lacrimal sac with canalicular involvement. Indian J Ophthalmol. 2019;67(2):279. h ttps://do i.org /10 .4103 /ijo .lj0_1348_18 57. Bradbury JA, Rennie IG , Parsons MA. Adrenaline dacryolith: detection by ultrasound exam ination o f the nasolacrimal duct. Br J Ophthalmol. 1988; 72(12):935-937. https://doi.org/10.1136/bjo.72.12.935 58. Spaeth GL. Nasolacrimal duct obstruction caused by topical epinephrine. Arch Ophthalmol. 1967;77(3):355-357. 59. Levine MR, Seipel SB, P lesecTP , Costin BR. Amyloid Pseudo-Dacryolith and Nasolacrimal Obstruction in a 67-Year-Old Male. Ophthalmic Plast Re­ constr Surg. 2017;33(4):86-88. https://doi.org/10.1097/10p.0000000000000791 60. Marcet MM, Roh JH , Mandeville JT, Woog JJ. Localized orbital amyloido­ sis involving the lacrimal sac and nasolacrimal duct. Ophthalmology. 2006; 113(1): 153-156. h t tp s : //do i .O rg /10 .1016 /j.oph th a .2005 .09 .034 61. Wilkins RB, Pressly JP. Diagnosis and incidence o f lacrimal calculi. Oph­ thalmic Surg. 1980; 11(11 ):787-789. 62. Purgason PA, Hornblass A, Loeffler M. Atypical presentation o f fungal dac­ ryocystitis. A report o f two cases. Ophthalmology. 1992;99(9): 1430-1432. 63. Iliadclis ED, Karabatakis VE, Sofoniou MK. Dacryoliths in a series o f dac­ ryocystorhinostomies: histologic and chemical analysis. Eur J Ophthalmol. 2006; l6(5):657-662. 64. Berlin AJ, Rath R, Rich L. Lacrimal system dacryoliths. Ophthalmic Surg. 1980; 11(7):435-436. 65. Ozer S, Ozer PA, Ortarik Z, Tuncer SC, Gullu B, Kadioglu YK. Analysis o f inorganic elements in a dacryolith using polarised X-ray fluorescence spec­ trometry: a case report. Eye (Lond). 2012;26(6):887. h ttp s : / /d o i .o rg /10.1038/eye.2012.36 66 . Cassotis NJ, Schiffman P. Calcification associated with the nasolacrimal sys­ tem o f a horse: case report and mineralogic composition. Vet Ophthalmol. 2006:9(3): 187-190. h ttps://doi.org/10.111 1 / j . 1463-5224.2006.00454.X 67. Malho P, Sansom J, Johnson P, Stewart J. Canine dacryolithiasis: a case de­ scription and mineral analysis. Vet Ophthalmol. 2013;16(4):289-296. h ttp s ://do i.o rg /10 .! 111/j. 1463-5224.2012.01065.x

Поступила 24.06.2019 Received 24.06.2019 Принята к печати 09.10.2019 Accepted 09.10.2019

83

RUSSIAN ANNALS OF OPHTHALMOLOGY 6, 2020